Volpara Health Technologies SMA 50
Quel est le SMA 50 de Volpara Health Technologies?
Le SMA 50 de Volpara Health Technologies Limited est AUD$1 +0.44%
Quelle est la définition de SMA 50?
SMA 50 est un cours moyen des 50 derniers jours calculé comme une moyenne non pondérée des 50 derniers cours de clôture.
Simple moving average of 50 days for a stock is an unweighted moving average over the past 50 days. Moving averages will always exhibit a lag and the longer the period used for averaging the greater the lag will be. Because of the large amounts of data considered when calculating a long-term moving average, it takes a considerable amount of movement in the market to cause the moving average to change its course.
Using a moving average to confirm a trend in price is one of the most basic, yet effecting ways of using the indicator. Moving averages take into account what has already happened and a whole range of past events, which makes them such a good technical analysis tool for trend confirmations. Generally, a long-term moving average that is clearly on the upswing is a confirmation of a bullish trend. Conversely, a long-term moving average that is clearly on the downswing is a confirmation of a bearish trend.
SMA 50 des entreprises dans Health Care secteur sur ASX par rapport à Volpara Health Technologies
Que fait Volpara Health Technologies?
Volpara Health Technologies Limited provides breast imaging analytics and analysis products for the early detection of breast cancer in the medical device and practice management software industry worldwide. The company offers Volpara Analytics software, a cloud-based breast imaging analytics platform that delivers performance monitoring solutions; Volpara Live, which provides radiographers instant patient-based image quality feedback; Volpara Lung, a patient management software; and Volpara Patient Hub, a customizable mammography reporting and patient communications software. It also offers Volpara Risk, an integration with Patient Hub that uses Tyrer-Cuzick v8 Risk Evaluation Tool to calculate patients' risk of developing breast cancer; Volpara Scorecard, which displays patient breast density and risk insights essential for improved clinical decision-making and early detection; and Volpara Science, an AI-based software that powers Volpara software products. In addition, the company provides TruDensity, a Volpara clinical function; TruPGMI, a Volpara clinical function, which uses artificial intelligence to automatically and objectively assess the positioning of the patient and resulting image quality; TruPressure, a Volpara clinical function, which determines whether the compression pressure applied by the radiographer is in the sweet spot that yields quality images, minimal radiation exposure, and the least discomfort; and TruRadDose, a Volpara clinical function which analyses the radiation dose delivered to patients based on their breast density. Volpara Health Technologies Limited has a strategic relationship with RevealDx to enhance lung screening capabilities. The company was formerly known as Matakina Technology Ltd. and changed its name to Volpara Health Technologies Limited in October 2015. Volpara Health Technologies Limited was incorporated in 2009 and is headquartered in Wellington, New Zealand.
Entreprises avec sma 50 similaire à Volpara Health Technologies
- CBAK Technology Inc a SMA 50 de $1 -19.47%
- China Merchants Commercial Real Estate Investment Trust a SMA 50 de HKD$1 +0.19%
- China Merchants Coml Reit a SMA 50 de $1 +0.19%
- Nacon S.A a SMA 50 de €1 -25.92%
- Civitas Social Housing Plc a SMA 50 de GBX1 +98.98%
- Millennium Services a SMA 50 de AUD$1 +0.57%
- Volpara Health Technologies a SMA 50 de AUD$1 +0.44%
- Smart-Core a SMA 50 de HKD$1 +15.53%
- China Oriental a SMA 50 de HKD$1 -5.62%
- Skillful Craftsman Education Technology a SMA 50 de $1 -7.69%
- Smartpay a SMA 50 de AUD$1 -20.16%
- Osmotica Pharmaceuticals Plc a SMA 50 de $1 -2.88%
- Wheelock and a SMA 50 de HKD$1 -10.10%